DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 156 filers reported holding DIPLOMAT PHARMACY INC in Q4 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,272,000 | -3.1% | 63,403 | 0.0% | 0.55% | -6.3% |
Q3 2017 | $1,313,000 | +81.4% | 63,403 | +29.6% | 0.59% | +77.6% |
Q2 2017 | $724,000 | -33.0% | 48,938 | -27.7% | 0.33% | -23.3% |
Q1 2017 | $1,080,000 | +161.5% | 67,686 | +106.6% | 0.43% | +151.5% |
Q4 2016 | $413,000 | -55.0% | 32,768 | 0.0% | 0.17% | -56.8% |
Q3 2016 | $918,000 | -20.0% | 32,768 | 0.0% | 0.40% | -26.3% |
Q2 2016 | $1,147,000 | +27.7% | 32,768 | 0.0% | 0.54% | +25.2% |
Q1 2016 | $898,000 | -19.9% | 32,768 | 0.0% | 0.43% | -20.0% |
Q4 2015 | $1,121,000 | +19.1% | 32,768 | 0.0% | 0.54% | +12.1% |
Q3 2015 | $941,000 | -35.8% | 32,768 | 0.0% | 0.48% | -28.1% |
Q2 2015 | $1,466,000 | +29.4% | 32,768 | 0.0% | 0.66% | +28.6% |
Q1 2015 | $1,133,000 | – | 32,768 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 445,200 | $7,101,000 | 1.80% |
Redmile Group, LLC | 1,254,342 | $20,007,000 | 1.30% |
Irving Magee Investment Management | 166,505 | $2,656,000 | 1.02% |
BROADVIEW ADVISORS LLC | 376,050 | $5,998,000 | 0.83% |
Sivik Global Healthcare LLC | 101,000 | $1,611,000 | 0.75% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 5,455,461 | $87,015,000 | 0.64% |
Iguana Healthcare Management, LLC | 75,000 | $1,196,000 | 0.59% |
RIVERBRIDGE PARTNERS LLC | 1,464,286 | $23,355,000 | 0.47% |
HERMES INVESTMENT MANAGEMENT LTD | 1,772,777 | $28,276,000 | 0.46% |
Endurant Capital Management LP | 85,043 | $1,356,000 | 0.44% |